# Bpifrance

> Bpifrance is a VC fund backing Software and Information Technology. See 1,471 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Maisons-alfort, France
- Total investments: 1,471
- Last investment: Jul 2026
- Lead investor: 26%
- Last fund: Mar 2025
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/bpifrance
- X (Twitter): http://twitter.com/bpifrance
- Website: http://bpifrance.fr
- Facebook: http://www.facebook.com/bpifrance

Bpifrance is a VC fund in Maisons-alfort focused on Software and Information Technology. Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

## Contacts

5 contacts available for Bpifrance. Shizune tracks 32 team members at Bpifrance. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bpifrance?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $757k–$6.3M |
| Series A | $3M–$34M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 156 | 11% |
| Information Technology | 102 | 7% |
| Health Care | 94 | 6% |
| Biotechnology | 89 | 6% |
| Manufacturing | 74 | 5% |

418 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 254 | 17% |
| Funding Round | 223 | 15% |
| Series A | 133 | 9% |
| Series B | 81 | 6% |
| Pre-Seed | 42 | 3% |

17 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 744 | 51% |
| United States | 25 | 2% |
| Switzerland | 4 | 0% |
| Brazil | 2 | 0% |
| Canada | 2 | 0% |

14 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adrien Neel | Investment Director | 2 | https://shizune.co/investors/profile/adrien-neel |
| Cédric Clement | Senior Investment Director \| Bpifrance Deeptech Venture | 1 | https://shizune.co/investors/profile/c%C3%A9dric-clement |
| Charlotte Corbaz | Investment Drector - Large Venture | 3 | https://shizune.co/investors/profile/charlotte-corbaz |
| Clarisse Blandin | Investment director | 2 | https://shizune.co/investors/profile/clarisse-blandin-2 |
| Laure Michel | Investment Director | 5 | https://shizune.co/investors/profile/laure-michel |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Apolownia | Apolownia operates an integrated development platform that designs, implements, and monitors high-integrity coastal ecosystem restoration and blue carbon projects. The company centralizes the entire project chain from site identification and feasibility to remote sensing and long-term verification to provide transparent, measurable carbonsequestration solutions. Its value proposition lies in helping corporate clients and investment funds fulfill stringent climate targets through premium verified carbon credits that demonstrate a clear, durable impact on biodiversity and local communities. | $1.2M | Seed | Jul 31, 2026 |  |
| Ascendance | Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsionsystem ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’. | $15.9M | Series B | Jul 27, 2026 |  |
| Brenus Pharma | Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $12.6M | Series A | Jul 20, 2026 |  |
| ENGO Eyewear | ENGO Eyewear is a specialist tech company that designs and builds high performance smart glasses tailored specifically for endurance athletes like runners, cyclists, and triathletes. | $5.8M | Seed | Jul 17, 2026 |  |
| Syntetica | Syntetica is a materials technology and climate technology company that develops chemical recycling technology for synthetic textiles. It uses proprietary green chemistry to convert nylon textile waste into virgin-quality recycled polymers, enabling circular production for the textile, automotive, and industrial materials industries. Its mission isto decarbonize synthetic materials by making high-quality recycled feedstocks commercially viable.The company's proprietary chemical depolymerization process separates and recovers Nylon 6 and Nylon 6,6 from blended textile waste that would otherwise be difficult to recycle. The process operates under low-temperature, low-pressure conditions, removes dyes and finishes, and produces recycled raw materials that can be reintroduced into manufacturing without compromising quality. Syntetica's technology supports textile-to-textile recycling and is designed to reduce carbon emissions, landfill waste, and reliance on virgin fossil-based materials. | $30M | Series A | Jul 16, 2026 |  |
| Stracker | STRACKER offers a digital platform for commission-free global freight forwarding. | $2.9M | Seed | Jul 15, 2026 |  |
| En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies that enable the rapid detection of DNA and RNA pathogens at the point of care. The company designs programmable diagnostic platforms that deliver laboratory-grade molecular testing without requiring specialized equipment or extensive technical training. Its technology uses syntheticbiology and portable diagnostic devices to support the detection of infectious diseases, including Lyme disease, as well as other bacterial and viral pathogens. En Carta Diagnostics also develops custom molecular diagnostic solutions and expands its platform to address a broad range of genetic and infectious disease applications. The company collaborates with research institutions and applies its proprietary diagnostic technology to improve the accessibility and reliability of molecular testing across healthcare settings. | $2.3M | Grant | Jul 10, 2026 |  |
| Cyllene Therapeutics | EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy. | $37.7M | Series C | Jul 07, 2026 |  |
| Elixir Aircraft | Elixir Aircraft is an aerospace company that provides aircraft, component manufacturing, and training services. | $51.4M | Venture - Series Unknown | Jul 02, 2026 |  |
| Beams | Beams is a producer of medical devices for cancerology based on the use of particles β. | $1.7M | Seed | Jun 26, 2026 |  |

10 of 1,471 investments shown.

## Co-investors
- [BNP Paribas](https://shizune.co/investors/profile/bnp-paribas) — VC Fund, 65 deals together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 63 deals together
- [BNP Paribas Développement](https://shizune.co/investors/profile/bnp-paribas-developpement) — VC Fund, 51 deals together
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund, 49 deals together
- [Crédit Agricole](https://shizune.co/investors/profile/credit-agricole) — VC Fund, 39 deals together
- [Supernova Invest](https://shizune.co/investors/profile/supernova-invest) — VC Fund, 36 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## Featured in investor lists
- [All Investors](https://shizune.co/investors/investors)
- [All Investors in Europe](https://shizune.co/investors/investors-europe)
- [All VC Funds in Europe](https://shizune.co/investors/vc-funds-europe)
- [All Investors in France](https://shizune.co/investors/investors-france)
- [All VC Funds in France](https://shizune.co/investors/vc-funds-france)
- [SaaS Investors](https://shizune.co/investors/saas-investors)

## FAQ

### What does Bpifrance invest in?

Bpifrance invests primarily in Software, Information Technology and Health Care startups, most often at Seed and Funding Round stage. Most of the 1,471 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Bpifrance's check size?

Bpifrance typically joins rounds of $757k–$6.3M at Seed and $3M–$34M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bpifrance participates in.

### How do I contact Bpifrance?

Public channels for Bpifrance include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bpifrance?

The team at Bpifrance includes Adrien Neel (Investment Director), Cédric Clement (Senior Investment Director | Bpifrance Deeptech Venture) and Charlotte Corbaz (Investment Drector - Large Venture), among 32 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co